Further experiences with moderate dosage sodium fluoride for sensorineural hearing loss, tinnitus and vertigo due to otospongiosis.
D000818:Animals; D002214:Capsules; D003638:Deafness / Q000188:drug therapy* / Q000209:etiology; D005459:Fluorides / Q000627:therapeutic use*; D006801:Humans; D010040:Otosclerosis / Q000150:complications*; D012969:Sodium Fluoride / Q000008:administration & dosage / Q000627:therapeutic use*; D013607:Tablets; D014012:Tinnitus / Q000188:drug therapy*; D014717:Vertigo / Q000188:drug therapy* / Q000209:etiology
D002214:Capsules; D013607:Tablets; D012969:Sodium Fluoride; D005459:Fluorides